These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 7681223)

  • 1. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
    Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
    Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activation in vivo upon intravenous infusion of DDAVP. Quantitative assessment of plasmin-alpha 2-antiplasmin complex with a novel monoclonal antibody based radioimmunoassay.
    Levi M; de Boer JP; Roem D; ten Cate JW; Hack CE
    Thromb Haemost; 1992 Jan; 67(1):111-6. PubMed ID: 1377412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
    Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
    Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of coagulation and fibrinolysis by plasma proteinase inhibitors.
    Travis J; Salvesen G
    Behring Inst Mitt; 1983 Aug; (73):56-65. PubMed ID: 6206838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
    Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
    J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma proteinase inhibitors.
    Bodmer JL; Schnebli HP
    Schweiz Med Wochenschr; 1984 Oct; 114(40):1359-63. PubMed ID: 6208604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteases and protease inhibitors in cerulein-induced acute pancreatitis in rats.
    Kruse P; Lasson A; Hage E
    J Surg Res; 1999 Aug; 85(2):294-300. PubMed ID: 10423332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of structural features of macroglobulins complexed with plasmin].
    Zhabin SG; Zorin NA; Gorin VS; Lykova OF
    Vopr Med Khim; 1993; 39(4):53-6. PubMed ID: 8379118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between antiplasmin capacity and concentration of alpha 2-plasmin inhibitor, alpha 2-macroglobulin, alpha 1-antitrypsin, antithrombin III or C1-inactivator in plasma of patients with transient ischemic attacks (author's transl)].
    Matsuda T; Seki T; Miura R; Ogawara M; Yokouchi M; Yamanouchi H
    Rinsho Byori; 1980 Mar; 28(3):261-4. PubMed ID: 6154815
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in plasma levels of protease and fibrinolytic inhibitors induced by treatment in acute myeloid leukemia.
    Velasco F; Torres A; Andres P; Martinez F; Gomez P
    Thromb Haemost; 1984 Aug; 52(1):81-4. PubMed ID: 6238445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of protein C and its distribution between its inhibitors, protein C inhibitor, alpha 1-antitrypsin and alpha 2-macroglobulin, in patients with disseminated intravascular coagulation.
    Scully MF; Toh CH; Hoogendoorn H; Manuel RP; Nesheim ME; Solymoss S; Giles AR
    Thromb Haemost; 1993 May; 69(5):448-53. PubMed ID: 7686692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmin inactivation in plasma.
    Haselager EM; Goote TM; Vreeken J
    Thromb Haemost; 1976 Jun; 35(3):643-50. PubMed ID: 62411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The measurement of human plasma antiplasmin activity by radial diffusion assay.
    Andes WA
    Thromb Haemost; 1978 Apr; 39(2):437-49. PubMed ID: 79230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An enzyme-linked immunosorbent assay (ELISA) for the measurement of plasmin-alpha 2-antiplasmin complex in human plasma--application to the detection of in vivo activation of the fibrinolytic system.
    Holvoet P; de Boer A; Verstreken M; Collen D
    Thromb Haemost; 1986 Oct; 56(2):124-7. PubMed ID: 2433784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elastosis in breast carcinoma: II. Association of protease inhibitors with immature elastic fibres.
    Davies JD; Mera SL
    J Pathol; 1987 Dec; 153(4):317-24. PubMed ID: 2448440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The protease inhibitor potential in newborns with respiratory distress syndrome].
    Weissbach G; Domula M; Lenk H; Rogos R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(1):89-102. PubMed ID: 88394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of factor Xia in vivo: studies in chimpanzees and in humans.
    Wuillemin WA; Hack CE; Bleeker WK; Biemond BJ; Levi M; ten Cate H
    Thromb Haemost; 1996 Oct; 76(4):549-55. PubMed ID: 8902995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum antithrombin III and alpha-2-antiplasmin concentration in patients with lung carcinoma.
    Dabrowska M; Prokopowicz J; Kemona H; Kretowska J; Kulik S; Głuszczak M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(5):641-6. PubMed ID: 2465244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate.
    Teger-Nilsson AC; Friberger P; Gyzander E
    Scand J Clin Lab Invest; 1977 Sep; 37(5):403-9. PubMed ID: 73215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.